Home › Juvenile Arthritis › Texas
Juvenile Arthritis clinical trials in Texas
4 studies for Juvenile Arthritis are looking for participants at sites in Texas.
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
- Texas Arthritis Center, El Paso
RecruitingPhase 1
Ages 2 to 17 · All sexes · Updated Sep 28, 2026 · NCT06751238A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cook Childrens Medical Center, Fort Worth
RecruitingPhase 3
Ages 3 and older · All sexes · Updated Sep 25, 2026 · NCT06663332A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Child Neurology Consultants of Austin /ID# 260562, Austin
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 1, 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- University of Texas Southwestern Medical Center Dallas, Dallas
- Baylor College of Medicine Pediatric Immunology Allergy Rheumatology, Houston
RecruitingObservational study
Up to age 21 · All sexes · Updated Aug 27, 2026 · NCT02418442From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.